First AI-Generated Drug Enters Human Clinical Trials, Targeting Patients With Chronic Lung Diseases

Insilico Medicines CEO Alex Zhavoronkov (left) said the drug would undergo the same tests to ascertain its efficacy and safety.

Technician By Melissa Rudy, Fox News June 29, 2023 | 1:17 The first AI-generated drug has entered Phase 2 clinical trials, with the first dose successfully administered to a human, Insilico Medicine announced yesterday. The drug, currently called INS018_055, is being tested for the treatment of idiopathic pulmonary fibrosis (IPF), a rare and progressive type … Read more